loadpatents
Patent applications and USPTO patent grants for Olejniczak; Edward T..The latest application filed is for "substituted indole mcl-1 inhibitors".
Patent | Date |
---|---|
Substituted indole Mcl-1 inhibitors Grant 11,208,415 - Lee , et al. December 28, 2 | 2021-12-28 |
Substituted Indole Mcl-1 Inhibitors App 20210283138 - Lee; Taekyu ;   et al. | 2021-09-16 |
Substituted indole Mcl-1 inhibitors Grant 10,954,193 - Lee , et al. March 23, 2 | 2021-03-23 |
Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors Grant 10,844,032 - Lee , et al. November 24, 2 | 2020-11-24 |
Substituted Indole Mcl-1 Inhibitors App 20200140447 - Lee; Taekyu ;   et al. | 2020-05-07 |
Substituted indole Mcl-1 inhibitors Grant 10,533,010 - Lee , et al. Ja | 2020-01-14 |
WDR5 inhibitors and modulators Grant 10,501,466 - Fesik , et al. Dec | 2019-12-10 |
Wdr5 Inhibitors And Modulators App 20190084988 - Fesik; Stephen W. ;   et al. | 2019-03-21 |
WDR5 inhibitors and modulators Grant 10,160,763 - Fesik , et al. Dec | 2018-12-25 |
Substituted Benzofuran, Benzothiophene And Indole Mcl-1 Inhibitors App 20180312485 - Lee; Taekyu ;   et al. | 2018-11-01 |
Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors Grant 10,093,640 - Lee , et al. October 9, 2 | 2018-10-09 |
Substituted Indole Mcl-1 Inhibitors App 20180258039 - Lee; Taekyu ;   et al. | 2018-09-13 |
Substituted indole Mcl-1 inhibitors Grant 10,005,728 - Lee , et al. June 26, 2 | 2018-06-26 |
Tricyclic indole Mcl-1 inhibitors and uses thereof Grant 9,949,965 - Lee , et al. April 24, 2 | 2018-04-24 |
Wdr5 Inhibitors And Modulators App 20180086767 - Fesik; Stephen W. ;   et al. | 2018-03-29 |
Substituted Indole Mcl-1 Inhibitors App 20170174689 - Lee; Taekyu ;   et al. | 2017-06-22 |
Substituted Indole Mcl-1 Inhibitors App 20160214934 - Lee; Taekyu ;   et al. | 2016-07-28 |
Tricyclic Indole Mcl-1 Inhibitors And Uses Thereof App 20160106731 - Lee; Taekyu ;   et al. | 2016-04-21 |
Substituted Benzofuran, Benzothiophene And Indole Mcl-1 Inhibitors App 20150336925 - Lee; Taekyu ;   et al. | 2015-11-26 |
Antibodies that bind to mammalian NGAL and uses thereof Grant 8,846,036 - Birkenmeyer , et al. September 30, 2 | 2014-09-30 |
Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins Grant 8,263,558 - Holzman , et al. September 11, 2 | 2012-09-11 |
Immunoassays And Kits For The Detection Of Ngal App 20100227775 - Birkenmeyer; Larry G. ;   et al. | 2010-09-09 |
Immunoassays And Kits For The Detection Of Ngal App 20090269777 - Birkenmeyer; Larry G. ;   et al. | 2009-10-29 |
Antibodies That Bind To Mammalian Ngal And Uses Thereof App 20090263894 - Birkenmeyer; Larry G. ;   et al. | 2009-10-22 |
Methods Of Preparation Of Recombinant Forms Of Human Beta-amyloid Protein And Uses Of These Proteins App 20090214515 - Holzman; Thomas F. ;   et al. | 2009-08-27 |
Antibodies That Bind To Mammalian Ngal And Uses Thereof App 20090124022 - Birkenmeyer; Larry G. ;   et al. | 2009-05-14 |
Immunoassays And Kits For The Detection Of Ngal App 20090123946 - Birkenmeyer; Larry G. ;   et al. | 2009-05-14 |
Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules Grant 6,043,024 - Fesik , et al. March 28, 2 | 2000-03-28 |
Use of nuclear magnetic resonance to design ligands to target biomolecules Grant 5,989,827 - Fesik , et al. November 23, 1 | 1999-11-23 |
Use of nuclear magnetic resonance to design ligands to target biomolecules Grant 5,891,643 - Fesik , et al. April 6, 1 | 1999-04-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.